According to the research report, the global bloodbank market size is expected to touch USD 24.78 Billion by 2032, from USD 24.78 Billion in 2022, growing with a significant CAGR of 3.66% from 2023 to 2032.
The blood bank report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global blood bank in conjunction with the
geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global blood bank market, which aids companies
operating in the market in making strategic development decisions. The study
also elaborates on significant changes that are highly anticipated to configure
growth of the global blood bank during the forecast period. It also includes a
key indicator assessment that highlights growth prospects of this market and
estimates statistics related to growth of the market in terms of value (US$ Mn)
and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/2537
| Report Coverage | Details |
| Market Size in 2023 | USD 17.92 Billion |
| Market Size by 2032 | USD 24.78 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 3.66% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Function, By Bank Type and By End User |
This study covers a detailed segmentation
of the global blood bank market, along with key information and a competition
outlook. The report mentions company profiles of players that are currently
dominating the global blood bank market, wherein various developments,
expansions, and winning strategies practiced and implemented by leading players
have been presented in detail.
Key Players
- America's Blood Centers
- Australian Red Cross Society
- Blood Bank of Alaska
- Canadian Blood Services
- Japanese Red Cross Society
- New York Blood Center
- Sanquin Blood Supply Foundation
- The American Red Cross
- Vitalant
- NHS Blood and Transplant
- National Blood Transfusion Council
- Shire
Market Segmentation
- Whole Blood
- Red Blood Cells
- Platelets
- Plasma
- White Blood Cells
By Function
- Collection
- Processing
- Testing
- Storage
- Transportation
By Bank Type
- Private
- Public
By End User
- Hospital
- Ambulatory Surgery Centers
- Pharmaceutical Companies
- Clinics and Nursing Homes
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- The Middle East and Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global blood bank report is based on detailed
primary as well as secondary research. With the help of in-depth insights of
the market-affiliated information that is obtained and legitimated by
market-admissible resources, analysts have offered riveting observations and authentic
forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global blood bank market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Blood Bank Market
5.1. COVID-19 Landscape: Blood Bank Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Blood Bank Market, By Product
8.1. Blood Bank Market, by Product, 2023-2032
8.1.1. Whole Blood
8.1.1.1. Market Revenue and Forecast (2023-2032)
8.1.2. Red Blood Cells
8.1.2.1. Market Revenue and Forecast (2023-2032)
8.1.3. Platelets
8.1.3.1. Market Revenue and Forecast (2023-2032)
8.1.4. Plasma
8.1.4.1. Market Revenue and Forecast (2023-2032)
8.1.5. White Blood Cells
8.1.5.1. Market Revenue and Forecast (2023-2032)
Chapter 9. Global Blood Bank Market, By Function
9.1. Blood Bank Market, by Function, 2023-2032
9.1.1. Collection
9.1.1.1. Market Revenue and Forecast (2023-2032)
9.1.2. Processing
9.1.2.1. Market Revenue and Forecast (2023-2032)
9.1.3. Testing
9.1.3.1. Market Revenue and Forecast (2023-2032)
9.1.4. Storage
9.1.4.1. Market Revenue and Forecast (2023-2032)
9.1.5. Transportation
9.1.5.1. Market Revenue and Forecast (2023-2032)
Chapter 10. Global Blood Bank Market, By Bank Type
10.1. Blood Bank Market, by Bank Type, 2023-2032
10.1.1. Private
10.1.1.1. Market Revenue and Forecast (2023-2032)
10.1.2. Public
10.1.2.1. Market Revenue and Forecast (2023-2032)
Chapter 11. Global Blood Bank Market, By End User
11.1. Blood Bank Market, by End User, 2023-2032
11.1.1. Hospital
11.1.1.1. Market Revenue and Forecast (2023-2032)
11.1.2. Ambulatory Surgery Centers
11.1.2.1. Market Revenue and Forecast (2023-2032)
11.1.3. Pharmaceutical Companies
11.1.3.1. Market Revenue and Forecast (2023-2032)
11.1.4. Clinics and Nursing Homes
11.1.4.1. Market Revenue and Forecast (2023-2032)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2023-2032)
Chapter 12. Global Blood Bank Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2023-2032)
12.1.2. Market Revenue and Forecast, by Function (2023-2032)
12.1.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.1.4. Market Revenue and Forecast, by End User (2023-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2023-2032)
12.1.5.2. Market Revenue and Forecast, by Function (2023-2032)
12.1.5.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.1.5.4. Market Revenue and Forecast, by End User (2023-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2023-2032)
12.1.6.2. Market Revenue and Forecast, by Function (2023-2032)
12.1.6.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.1.6.4. Market Revenue and Forecast, by End User (2023-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2023-2032)
12.2.2. Market Revenue and Forecast, by Function (2023-2032)
12.2.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.2.4. Market Revenue and Forecast, by End User (2023-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2023-2032)
12.2.5.2. Market Revenue and Forecast, by Function (2023-2032)
12.2.5.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.2.5.4. Market Revenue and Forecast, by End User (2023-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2023-2032)
12.2.6.2. Market Revenue and Forecast, by Function (2023-2032)
12.2.6.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.2.6.4. Market Revenue and Forecast, by End User (2023-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2023-2032)
12.2.7.2. Market Revenue and Forecast, by Function (2023-2032)
12.2.7.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.2.7.4. Market Revenue and Forecast, by End User (2023-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2023-2032)
12.2.8.2. Market Revenue and Forecast, by Function (2023-2032)
12.2.8.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.2.8.4. Market Revenue and Forecast, by End User (2023-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2023-2032)
12.3.2. Market Revenue and Forecast, by Function (2023-2032)
12.3.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.3.4. Market Revenue and Forecast, by End User (2023-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2023-2032)
12.3.5.2. Market Revenue and Forecast, by Function (2023-2032)
12.3.5.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.3.5.4. Market Revenue and Forecast, by End User (2023-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2023-2032)
12.3.6.2. Market Revenue and Forecast, by Function (2023-2032)
12.3.6.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.3.6.4. Market Revenue and Forecast, by End User (2023-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2023-2032)
12.3.7.2. Market Revenue and Forecast, by Function (2023-2032)
12.3.7.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.3.7.4. Market Revenue and Forecast, by End User (2023-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2023-2032)
12.3.8.2. Market Revenue and Forecast, by Function (2023-2032)
12.3.8.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.3.8.4. Market Revenue and Forecast, by End User (2023-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2023-2032)
12.4.2. Market Revenue and Forecast, by Function (2023-2032)
12.4.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.4.4. Market Revenue and Forecast, by End User (2023-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2023-2032)
12.4.5.2. Market Revenue and Forecast, by Function (2023-2032)
12.4.5.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.4.5.4. Market Revenue and Forecast, by End User (2023-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2023-2032)
12.4.6.2. Market Revenue and Forecast, by Function (2023-2032)
12.4.6.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.4.6.4. Market Revenue and Forecast, by End User (2023-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2023-2032)
12.4.7.2. Market Revenue and Forecast, by Function (2023-2032)
12.4.7.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.4.7.4. Market Revenue and Forecast, by End User (2023-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2023-2032)
12.4.8.2. Market Revenue and Forecast, by Function (2023-2032)
12.4.8.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.4.8.4. Market Revenue and Forecast, by End User (2023-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2023-2032)
12.5.2. Market Revenue and Forecast, by Function (2023-2032)
12.5.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.5.4. Market Revenue and Forecast, by End User (2023-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2023-2032)
12.5.5.2. Market Revenue and Forecast, by Function (2023-2032)
12.5.5.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.5.5.4. Market Revenue and Forecast, by End User (2023-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2023-2032)
12.5.6.2. Market Revenue and Forecast, by Function (2023-2032)
12.5.6.3. Market Revenue and Forecast, by Bank Type (2023-2032)
12.5.6.4. Market Revenue and Forecast, by End User (2023-2032)
Chapter 13. Company Profiles
13.1. America's Blood Centers
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Australian Red Cross Society
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Blood Bank of Alaska
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Canadian Blood Services
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Japanese Red Cross Society
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. New York Blood Center
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sanquin Blood Supply Foundation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. The American Red Cross
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Vitalant
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. NHS Blood and Transplant
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments